4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:March 16, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:March 16, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:March 16, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:March 16, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:March 10, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
S-8: Securities offered to employees pursuant to employee benefit plans Post author:andrewkaretas Post published:February 28, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingS-8: Securities offered to employees pursuant to employee benefit plans
10-K: Annual report which provides a comprehensive overview of the company for the past year Post author:andrewkaretas Post published:February 28, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading10-K: Annual report which provides a comprehensive overview of the company for the past year
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:February 28, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:February 14, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
SC 13G: A statement of beneficial ownership of common stock by certain persons Post author:andrewkaretas Post published:February 13, 2023 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSC 13G: A statement of beneficial ownership of common stock by certain persons
